Loading...
EUGIA US LLC, — Meropenem Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Meropenem · $4.1M import value · 82 shipments · UNITED STATES · DGFT Verified
EUGIA US LLC, is the #3 importer of Meropenem from India with $4.1M in import value and 82 verified shipments. EUGIA US LLC, holds a 1.8% market share in Meropenem imports based in UNITED STATES. The company sources from 1 verified supplier across 41 formulations shipped to 1 country. Overall, EUGIA US LLC, imports 27 pharmaceutical products worth $66.2M across 13 therapeutic categories.
Verified from 82 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $4.1M | 82 | 100.0% |
EUGIA US LLC, sources Meropenem from 1 verified Indian supplier based on 82 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $7.2M | 143 | $50.0K |
| 7 | S T C | SAUDI ARABIA | $4.4M | 95 | $46.2K |
| 3 | EUGIA US LLC, ★ | UNITED STATES | $4.1M | 82 | $50.0K |
| 8 | SALEHIYA TRADING COMPANY | SAUDI ARABIA | $3.2M | 64 | $50.0K |
| 5 | EUGIA US LLC ★ | UNITED STATES | $2.1M | 43 | $50.0K |
EUGIA US LLC, ranks #3 among 966 Meropenem importers from India. Average shipment value of $50.0K compared to the market average of $38.7K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and S T C.
Destination countries from 82 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.1M | 82 | 100.0% |
EUGIA US LLC, imports Meropenem to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $4.1M.
| Formulation | Value | Shipments |
|---|---|---|
| MEROPENEM FOR INJECTION 1 G/VIAL (Merope | $1.1M | 21 |
| MEROPENEM FOR INJECTION 500 MG/VIAL (Mer | $250.0K | 5 |
| MEROPENEM FOR INJECTION 1 G/VIAL,(Merope | $150.0K | 3 |
| MEROPENEM FOR INJECTION 1 G/VIAL (MEROPENEM FOR INJECTION USP 1G / VIAL), BT#2MI24003A, MFG# 02/2024, EXP#01/2027 | $150.0K | 3 |
| MEROPENEM FOR INJECTION 1 G/VIAL (MEROPENEM FOR INJECTION USP 1G / VIAL), BT#2MI24002A, MFG# 02/2024, EXP#01/2027. | $150.0K | 3 |
| MEROPENEM FOR INJECTION 1 G/VIAL (MEROPENEM FOR INJECTION USP 1G / VIAL), BT#2MI24008A, MFG# 03/2024, EXP# 02/2027. | $150.0K | 3 |
| MEROPENEM FOR INJECTION 1 G/VIAL,(MEROPENEM FOR INJECTION USP 1G / VIAL)B NO.2MI24011A,MFT.DT.03/2024,EXP.02/2027 | $150.0K | 3 |
| MEROPENEM FOR INJECTION 1 G/VIAL (Meropenem For Injection USP, 1g), BT#2MI24116A, MFG#12/2024, EXP#11/2027 |
What EUGIA US LLC, and other importers must comply with to import Meropenem from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $37.3M worth of Meropenem through 3,658 shipments from 401 suppliers to 134 countries, serving 966 buyers globally. EUGIA US LLC, imports $4.1M of this total, accounting for 1.8% of India's Meropenem exports with 82 shipments from UNITED STATES. This is verified from 82 customs shipment records covering 41 distinct formulations.
EUGIA US LLC,'s average Meropenem order value is $50.0K per consignment, based on 82 shipments totaling $4.1M. EUGIA US LLC, is based in UNITED STATES and ranks #3 among all Meropenem importers from India by value. The company sources from 1 verified supplier in India.
EUGIA US LLC, sources Meropenem from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($4.1M, 100.0%). This is based on 82 customs records.
EUGIA US LLC, ranks #3 among 966 Meropenem importers from India with a 1.8% market share. The top 3 importers are VENUS PHARMA GMBH ($7.2M), YUSEN LOGISTICS BENELUX BELGIUM ($7.2M), S T C ($4.4M). EUGIA US LLC, processed 82 shipments from UNITED STATES.
EUGIA US LLC, also imports these advanced antibiotics products. Each links to the detailed product page.
EUGIA US LLC, imports 27 products worth $66.2M. Beyond Meropenem, top products include Ertapenem, Pantoprazole, Piperacillin, Sodium, Acetaminophen. View the complete EUGIA US LLC, profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Meropenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for EUGIA US LLC,'s Meropenem imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EUGIA US LLC,
Full Company Profile →
27 products · $66.2M total trade · 13 categories
| $100.0K |
| 2 |
| MEROPENEM FOR INJECTION 1 G/VIAL (Meropenem For Injection USP, 1g), BT#2MI25005A, MFG# 01/2025, EXP# 12/2027 | $100.0K | 2 |
| MEROPENEM FOR INJECTION 1 G/VIAL (Meropenem For Injection USP, 1g), BT#2MI25006A, MFG#01/2025, EXP# 12/2027 | $100.0K | 2 |
EUGIA US LLC, imports 41 distinct Meropenem formulations from India. The top formulation is MEROPENEM FOR INJECTION 1 G/VIAL (Merope with 21 shipments worth $1.1M.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 134+ countries, 966+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for EUGIA US LLC,.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Meropenem. For current order-level data, contact TransData Nexus.